Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Martina Mang Leng Lei et al.|Cancer Research|2022Cited by 106
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinomaHoi-Wing Leung, Terence K. Lee, Eunice Y. Lau et al.|Cancer Letters|2020Cited by 53
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinomaMartina Mang Leng Lei, Terence K. Lee|Nature Communications|2025Cited by 3
Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0
Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0